Bio
Francis Lunger is an Operating Partner at Linden with 30 years of healthcare and operating experience. Prior to joining Linden, Fran served as Chief Executive Officer of Millipore Corporation (NYSE: MIL), where he led a team that doubled the revenue growth rate, executed a spin-off of the microelectronics business unit (Mykrolis), and transitioned the remaining business from a product-oriented, multi-industry filter company to a market-oriented bioscience business. Prior to his experience at Millipore, Mr. Lunger served as Chief Financial Officer for Oak Industries, Chief Executive Officer of Nashua Corporation, Vice President at Raychem Corporation where he launched the medical division and established a joint venture with U.S. Surgical (Covidien) for the development of laparoscopic surgical instruments, and Baxter International where he worked on the team that built Travenol into a $600 million business. Mr. Lunger currently serves on the Board of Directors for DENTSPLY International Inc. (NasdaqGS:XRAY). Mr. Lunger served as a sergeant in the U.S. Army in Vietnam, earned a B.S. in accounting from Gannon University, and is a Certified Public Accountant.
Career
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Linden LLCEmail: [email protected] |